Meet Dr. Weissgerber

Dr. Weissgerber attended the Medical School of Ludwig-Maximillian University, Munich, Germany and served an internship at the Teaching Hospital of Ludwig-Maximillian University and graduated in 1981.

He completed a Fellowship in Clinical Pharmacology at the Medical University of South Carolina in Charleston, including: Training in Basic Research; Participation in Clinial Trials; Management of Patients in Hypertensive Clinic.

From 1982-1985, Dr. Weissgerber served a residency in internal medicine at Northeastern University, Aultman Hospital in Canton, Ohio.

In 1985, he began his practice in Orlando, Florida.

Publications:

Committee, H; Weissgerber, P. Clinical use of Heparin and heparinoids, excluding the treatment of thromboembolism. Heparin Structure, Cellular Function and Clinical Application. Edited by Norman H. McDuffie, Academic Press, 1979.

Gastpar, H.; Weissgerber, P. The inhibition of cancer cell stickiness, a model for investigation of platelet aggregation inhibitors in vivo V. The effect of peributol. J. Med. 12:1, 1981.

Abstract of Doctoral Thesis: the influence of hemostasis and immunosystem on tumor growth and metastasis formation, to be published.

Gastpar, H.; Weissgerber, P.; enzman, F. The inhibition of cancer cell stickiness: A model for investigation of platelet aggregation inhibitors in vivo VI. Effect of the sulfonyl urea derivatives, Glibenclamide, Gliclazide and HB 180 as well as the carboxylic acid derivative Megletinide. Res. Exp. Med. 170; 85-84, 1982.

Weissgerber, P. A polyacrylamide agar hydrogel material for the treatment of burns. Presented at the Eighth Annual Meeting of the Society for Biomaterials Symposium, Orlando, Florida, April 1982.

Gastpar, H.; Zoltobrocki, M.; Weissgerber, P. The inhibition of cancer cell stickiness by stomatostatin. Res. Exp. Med. 182, January 6, 1983.